![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 39, 25125-25131, September 25, 1998
From the Selecting effective antisense target sites on a
given mRNA molecule constitutes a major problem in antisense
therapeutics. By trial-and-error, only 1 in 18 (6%) of antisense
oligonucleotides designed to target the primary RNA transcript of tumor
necrosis factor-
Tetranucleotide GGGA Motif in Primary RNA Transcripts
NOVEL TARGET SITE FOR ANTISENSE DESIGN
,
,
, and
¶
Department of Pathology, Anatomy and Cell
Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 and the ¶ Center for Gene Pharmacotherapy, University of Chile,
Olivos 1007, Ojicina C-52, Independencia, Santiago, Chile
(TNF-
) strongly inhibited TNF-
synthesis.
Subsequent studies showed that the area in RNA targeted by antisense
oligonucleotides could be moved effectively 10-15 bases in either
direction from the original area. We observed that only molecules that
incorporated a tetranucleotide motif TCCC (complementary to GGGA on
RNA) yielded potent antisense oligonucleotides against TNF-
. A
comprehensive literature survey showed that this motif is unwittingly
present in 48% of the most potent antisense oligonucleotides reported in the literature. This finding was prospectively used to predict the
sequences of additional antisense oligonucleotides for the rat TNF-
primary RNA transcript. Over 50% of antisense constructs (13 of 22)
containing the TCCC motif were found to effectively inhibit TNF-
synthesis. Marked reductions in mRNA were also observed. This motif
was found to be most effective when targeting introns in the primary
RNA transcript, suggesting a nuclear localization for the antisense
action. Predicting target sites based on the presence of this motif in
primary RNA transcripts should be of value in the development on new
antisense pharmacotherapy.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. S. Bobola, S. Varadarajan, N. W. Smith, R. D. Goff, D. D. Kolstoe, A. Blank, B. Gold, and J. R. Silber Human Glioma Cell Sensitivity to the Sequence-Specific Alkylating Agent Methyl-Lexitropsin Clin. Cancer Res., January 15, 2007; 13(2): 612 - 620. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shao, Y. Wu, C. Y. Chan, K. McDonough, and Y. Ding Rational design and rapid screening of antisense oligonucleotides for prokaryotic gene modulation Nucleic Acids Res., November 14, 2006; 34(19): 5660 - 5669. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Joli, N. Bouchemal, A. Laigle, B. Hartmann, and E. Hantz Solution structure of a purine rich hexaloop hairpin belonging to PGY/MDR1 mRNA and targeted by antisense oligonucleotides Nucleic Acids Res., November 6, 2006; 34(20): 5740 - 5751. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Abe and E. T. Kool Flow cytometric detection of specific RNAs in native human cells with quenched autoligating FRET probes PNAS, January 10, 2006; 103(2): 263 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. I. Kruman, E. Schwartz, Y. Kruman, R. G. Cutler, X. Zhu, N. H. Greig, and M. P. Mattson Suppression of Uracil-DNA Glycosylase Induces Neuronal Apoptosis J. Biol. Chem., October 15, 2004; 279(42): 43952 - 43960. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Campbell, V. Bovenzi, and M. Szyf Methylated DNA-binding protein 2 antisense inhibitors suppress tumourigenesis of human cancer cell lines in vitro and in vivo Carcinogenesis, April 1, 2004; 25(4): 499 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Feng, Z. Tu, W. Wu, and C. Liang Inhibiting the Expression of DNA Replication-Initiation Proteins Induces Apoptosis in Human Cancer Cells Cancer Res., November 1, 2003; 63(21): 7356 - 7364. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arredondo, P. Munoz, C. V. Mura, and M. T. Nunez DMT1, a physiologically relevant apical Cu1+ transporter of intestinal cells Am J Physiol Cell Physiol, June 1, 2003; 284(6): C1525 - C1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Giddings, A. A. Shah, S. Freier, J. F. Atkins, R. F. Gesteland, and O. V. Matveeva Artificial neural network prediction of antisense oligodeoxynucleotide activity Nucleic Acids Res., October 1, 2002; 30(19): 4295 - 4304. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Silber, M. S. Bobola, A. Blank, K. D. Schoeler, P. D. Haroldson, M. B. Huynh, and D. D. Kolstoe The Apurinic/Apyrimidinic Endonuclease Activity of Ape1/Ref-1 Contributes to Human Glioma Cell Resistance to Alkylating Agents and Is Elevated by Oxidative Stress Clin. Cancer Res., September 1, 2002; 8(9): 3008 - 3018. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dias and C. A. Stein Antisense Oligonucleotides: Basic Concepts and Mechanisms Mol. Cancer Ther., March 1, 2002; 1(5): 347 - 355. [Full Text] [PDF] |
||||
![]() |
B. H. Lloyd, R. V. Giles, D. G. Spiller, J. Grzybowski, D. M. Tidd, and D. R. Sibson Determination of optimal sites of antisense oligonucleotide cleavage within TNF{alpha} mRNA Nucleic Acids Res., September 1, 2001; 29(17): 3664 - 3673. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Garver, G.-c. Tu, Q.-N. Cao, M. Aini, F. Zhou, and Y. Israel Eliciting the Low-Activity Aldehyde Dehydrogenase Asian Phenotype by an Antisense Mechanism Results in an Aversion to Ethanol J. Exp. Med., August 27, 2001; 194(5): 571 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Ponnappa, I. Dey, G.-c. Tu, F. Zhou, M. Aini, Q.-n. Cao, and Y. Israel In Vivo Delivery of Antisense Oligonucleotides in pH-Sensitive Liposomes Inhibits Lipopolysaccharide-Induced Production of Tumor Necrosis Factor-alpha in Rats J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1129 - 1136. [Abstract] [Full Text] |
||||
![]() |
M. Sohail, H. Hochegger, A. Klotzbucher, R. L. Guellec, T. Hunt, and E. M. Southern Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivo Nucleic Acids Res., May 15, 2001; 29(10): 2041 - 2051. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ducza, R. Gáspár, A. Márki, P. Gyula, S. Bottka, and G. Falkay Use of Antisense Oligonucleotides to Verify the Role of the alpha 1A-Adrenergic Receptor in the Contractility of the Rat Uterus Post Partum Mol. Pharmacol., April 16, 2001; 59(5): 1235 - 1242. [Abstract] [Full Text] |
||||
![]() |
O. V. Matveeva, A. D. Tsodikov, M. Giddings, S. M. Freier, J. R. Wyatt, A. N. Spiridonov, S. A. Shabalina, R. F. Gesteland, and J. F. Atkins Identification of sequence motifs in oligonucleotides whose presence is correlated with antisense activity Nucleic Acids Res., August 1, 2000; 28(15): 2862 - 2865. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Kang and J.-S. Kim Zinc Finger Proteins as Designer Transcription Factors J. Biol. Chem., March 17, 2000; 275(12): 8742 - 8748. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Vickers, J. R. Wyatt, and S. M. Freier Effects of RNA secondary structure on cellular antisense activity Nucleic Acids Res., March 15, 2000; 28(6): 1340 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Coulis, C. Lee, V. Nardone, and R. D. Prokipcak Inhibition of c-myc Expression in Cells by Targeting an RNA-Protein Interaction Using Antisense Oligonucleotides Mol. Pharmacol., March 1, 2000; 57(3): 485 - 494. [Abstract] [Full Text] |
||||
![]() |
B.-S. Herbert, A. E. Pitts, S. I. Baker, S. E. Hamilton, W. E. Wright, J. W. Shay, and D. R. Corey Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death PNAS, December 7, 1999; 96(25): 14276 - 14281. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Erl, G. K. Hansson, R. de Martin, G. Draude, K. S. C. Weber, and C. Weber Nuclear Factor-{kappa}B Regulates Induction of Apoptosis and Inhibitor of Apoptosis Protein-1 Expression in Vascular Smooth Muscle Cells Circ. Res., April 2, 1999; 84(6): 668 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hew, C. Lau, Z. Grzelczak, and F. W. Keeley Identification of a GA-rich Sequence as a Protein-binding Site in the 3'-Untranslated Region of Chicken Elastin mRNA with a Potential Role in the Developmental Regulation of Elastin mRNA Stability J. Biol. Chem., August 4, 2000; 275(32): 24857 - 24864. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |